Featured Press Releases

Bracco Diagnostics Inc. reaches one million injections milestone with its MRI agent, VUEWAY® (gadopiclenol)

Bracco Diagnostics Inc. reaches one million injections milestone with its MRI agent, VUEWAY® (gadopiclenol)

Cellares Launches Cell Q, the World’s First Automated cGMP QC Workcell for Cell Therapies

Cellares Launches Cell Q, the World’s First Automated cGMP QC Workcell for Cell Therapies

  • 18 Apr 2024

Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to...

Eximia Research Network expands into Virginia by integrating Tidewater Clinical Research

Eximia Research Network expands into Virginia by integrating Tidewater Clinical Research

Tentarix Biotherapeutics announces appointment of Andrew D. Kidd, MD, CFA, as CEO

Tentarix Biotherapeutics announces appointment of Andrew D. Kidd, MD, CFA, as CEO

Hanmi Pharmaceutical Launches

Hanmi Pharmaceutical Launches 'Aditams' in Mexico, Expanding into Latin America

Upsher-Smith Enhances Generics Portfolio by Introducing Difluprednate Ophthalmic Emulsion

Upsher-Smith Enhances Generics Portfolio by Introducing Difluprednate Ophthalmic Emulsion

Alamar Biosciences announces the launch of the NULISAqpcr™ AD 5-plex assay, advancing blood-based biomarker detection for Alzheimer’s disease research

Alamar Biosciences announces the launch of the NULISAqpcr™ AD 5-plex assay, advancing blood-based biomarker detection for Alzheimer’s disease research

  • Alamar Biosciences, Inc.
  • 13 Jan 2026
Ad Hoc Analyses Indicate Enhanced Survival Outcomes with VYLOY™ (zolbetuximab) Combined with Chemotherapy When Common Adverse Events Are Properly Managed

Ad Hoc Analyses Indicate Enhanced Survival Outcomes with VYLOY™ (zolbetuximab) Combined with Chemotherapy When Common Adverse Events Are Properly Managed

  • Astellas Pharma Inc
  • 12 Jan 2026
PureWay and PPSWG Form New Partnership to Transform Pharmaceutical Waste Management in the U.S.

PureWay and PPSWG Form New Partnership to Transform Pharmaceutical Waste Management in the U.S.

  • PureWay Compliance
  • 12 Jan 2026
Clover Begins Phase 2 Clinical Evaluation of a Combination Respiratory Vaccine Targeting RSV, hMPV, and ± PIV3

Clover Begins Phase 2 Clinical Evaluation of a Combination Respiratory Vaccine Targeting RSV, hMPV, and ± PIV3

  • Clover Biopharma
  • 12 Jan 2026
FDA Approves New 2-Gram Fibryga® Presentation to Improve Convenience and Precision in Treating Acquired Fibrinogen Deficiency

FDA Approves New 2-Gram Fibryga® Presentation to Improve Convenience and Precision in Treating Acquired Fibrinogen Deficiency

  • Octapharma
  • 08 Jan 2026
Ark Biopharmaceutical Granted China Marketing Authorization for Aizhida in ADHD Treatment

Ark Biopharmaceutical Granted China Marketing Authorization for Aizhida in ADHD Treatment

  • Arkbio
  • 08 Jan 2026
Drug Discovery 2024
The Digital Pharma Advances Conference 2026

Most Popular
January   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.